Skip to main content
HHS Author Manuscripts logoLink to HHS Author Manuscripts
. Author manuscript; available in PMC: 2017 Oct 30.
Published in final edited form as: J Correct Health Care. 2016 Apr;22(2):157–163. doi: 10.1177/1078345816635577

Awareness and Environmental Exposures Related to Coccidioidomycosis Among Inmates at Two California Prisons, 2013

Kaitlin Benedict 1, Anne E Purfield 1, Janet Mohle-Boetani 2, Charlotte Wheeler 2, Benjamin J Park 2
PMCID: PMC5661866  NIHMSID: NIHMS914943  PMID: 26984139

Abstract

Coccidioidomycosis (Valley fever) is a major cause of illness in inmates in some California prisons. This article discusses an investigation conducted at two prisons to describe potential environmental exposures. The study did not identify modifiable risk factors; limiting the type or duration of outdoor activity in these prisons may not decrease coccidioidomycosis morbidity.

Keywords: coccidioidomycosis, Valley fever, Coccidioides, prisons, California

Introduction

Coccidioidomycosis (Valley fever) is a fungal infection caused by inhalation of Coccidioides spp. arthroconidia. Symptomatic infection occurs in approximately 40% of cases and typically presents as a self-limited influenza-like illness, but a small proportion of patients experience severe or chronic pulmonary disease or life-threatening disseminated disease (Galgiani et al., 2005). Coccidioidomycosis is endemic to the southwestern United States, with hyperendemic foci in Arizona’s Sonoran Desert and California’s southern Central Valley.

Coccidioidomycosis is a substantial public health problem in prison inmates in some areas of California (Burwell et al., 2009; Pappagianis, 2007). During 2011, the incidence per 100,000 persons at prisons A and B was 5,189, which is 110 times higher than the combined rates of the nonprison populations in the counties where the prisons are located (Wheeler, Lucas, & Mohle-Boetani, 2015). Previous strategies to reduce coccidioidomycosis in this population involved exclusion of immunosuppressed inmates from eight prisons located in highly endemic areas beginning in August 2006 (California Correctional Health Care, 2012), cancelling planned construction at Prison B, implementation of educational and awareness efforts, and a cohort study to determine demographic and medical risk factors for infection among inmates who spent at least one night at Prison A or B in 2011. Prisons A and B house adult men, are structured similarly, and are located < 15 miles apart in California’s Central Valley, with arid surrounding areas and minimal vegetation on the prison grounds. No construction occurred at either prison during 2011.

It is not known if certain activities in these prisons are associated with higher risk of disease. As part of an epidemiologic investigation requested by corrections agency management, we evaluated potential exposures to understand if limitations on these exposures could contribute to reducing the likelihood of coccidioidomycosis.

Methods

Participant Selection

We conducted a nested case–control study using data from the subset of participants from the 2011 cohort study. Because the amount of allowable outdoor recreation time can vary by housing facility, case–control study participants were limited to those who had lived continuously at a single housing facility from January 1, 2011, to June 1, 2013. Cases were inmates who had documented coccidioidomycosis diagnosed in 2011 according to prison medical records, and controls were randomly selected inmates without coccidioidomycosis diagnosis. Three to five controls were matched to each case-inmate by prison (A or B), age group (18 to 35, 36 to 55, and ≥ 56 years), and race/ethnicity category.

Data Collection

Data on age, race/ethnicity, housing facility, and underlying medical conditions were from the cohort study. Additional data were collected on time spent outdoors, outdoor activities, occupation, exposure to dirt or dust, residence history, and knowledge of coccidioidomycosis during confidential in-person interviews using a standardized questionnaire. To minimize recall bias, participants were asked about the amount of time they currently spend outdoors as a proxy for the amount of time spent outdoors before they developed coccidioidomycosis (case-inmates) or before their matched case-inmate developed coccidioidomycosis (controls). The analysis of time spent outdoors was limited to participants who said that the amount of time they spend outdoors had not changed since 2011. Controls’ current outdoor recreational activities and current occupations were compared to those of their matched case-inmate before he developed coccidioidomycosis. Study participants were asked to provide a detailed lifetime residence history, including incarceration at other institutions. Two investigators independently categorized each location as “nonendemic,” “moderately endemic,” or “highly endemic” for coccidioidomycosis based on the categories of coccidioidin skin-test reactivity described in the 1957 report by Edwards and Palmer (1957). The highest level of coccidioidomycosis endemicity among prior residences was then recorded for each participant.

Statistical Analysis

Survey responses were entered into a Microsoft Access database and analyzed using Statistical Analysis Software (SAS, Version 9.3). Categorical variables were compared using χ2 or Fisher’s exact tests, and continuous variables were compared using Student’s t-test or Wilcoxon rank-sum tests, as appropriate. Logistic regression was used to calculate odds ratios (ORs) and 95% confidence intervals (CIs) for the matched case–control analysis. Two-sided p values of ≤ .05 were considered statistically significant.

Ethics Approval and Informed Consent

Due to the nature of the public health investigation, formal institutional review board approval was not necessary; however, we consulted human subjects’ research experts regarding the questionnaire design since prison inmates are considered a vulnerable population. Case-inmates and controls provided verbal consent to participate in the interviews, and no personally identifying information was collected.

Results

We identified 40 case-inmates and 174 controls: 17 and 23 case-inmates and 71 and 103 controls from prisons A and B, respectively. Case-inmates at prisons A and B were demographically similar (Table 1). Thirty-eight (95.0%) case-inmates were aware of their coccidioidomycosis diagnosis. Of those, 36 (94.7%) experienced symptoms, for a median of 14 days (range = 0 to 210) before diagnosis and 21 days (range = 0 to 570) after diagnosis. Thirty-eight (95.0%) reported receiving antifungal treatment (median = 24 weeks; range = 1 to 104). Median treatment duration was significantly longer at Prison A (46 weeks; range = 8 to 104) than at Prison B (24 weeks; range = 1 to 76; p = .037).

Table 1.

Description of Coccidioidomycosis Case-Inmates at Prisons A and B.

Characteristic Prison A (n = 17)
Prison B (n = 23)
p
n (%) n (%)
Age, years (median, range) 42.0 (26–64) 45.0 (24–62) .272
Race/ethnicity .678
 African American 6 (35.3) 9 (39.1)
 Hispanic 5 (29.4) 8 (34.8)
 White 6 (35.3) 5 (21.7)
 Other 0 (0.0) 1 (4.4)
Aware of coccidioidomycosis diagnosis 17 (100.0) 21 (91.3) .499
 Symptomatic 16 (94.1) 20 (95.2) 1.000
 Symptom duration, days (median, range) 24 (1–180) 70 (8–630) .132
 Before diagnosis (median, range) 14 (0–180) 14 (3–210) .716
 After diagnosis (median, range) 14 (0–120) 30 (2–570) .241
Received treatment for coccidioidomycosis 16 (94.1) 22 (95.6) .436
 Treatment duration, weeks (median, range) 46 (8–104) 24 (1–76) .037

Case-inmates and controls had similar proportions of underlying medical conditions such as hepatitis C, cardiac disease, diabetes, and asthma (Table 2). Approximately half of case-inmates (n = 20, 50.0%) and controls (n = 92, 52.9%) said that the amount of time they spend outdoors had not changed since their coccidioidomycosis diagnosis (case-inmates) or since January 1, 2011 (controls); median time spent outdoors was 19.9 hours per week (range = 3.5 to 45.5) for case-inmates and 17.3 (range = 0.0 to 77.0) for controls. The frequencies of various recreational activities were not significantly associated with case status. Both groups were also equally likely to have a job or be enrolled in an educational program (87.5% vs. 87.4%, OR = 0.96; 95% CI: [0.29, 3.72], p = 1.000). Similar proportions of case-inmates and controls reported breathing in dirt or dust outdoors (85.0% vs. 84.5%, OR = 1.19; CI: [0.35, 3.52], p = .917) and indoors (54.6% vs. 67.2%, OR = 0.50; CI: [0.19, 1.28], p = .164). Nearly all participants (n = 191, 90.1%) had previously lived in areas with high or moderate coccidioidomycosis endemicity, with no significant difference between case-inmates and controls.

Table 2.

Comparison of Coccidioidomycosis Case-Inmates and Controls at Prisons A and B Combined.

Characteristic Case-Inmates
Controls
OR (95% CI) p
n (%) n (%)
Demographics
 Age, years (median, range) 43.5 (24–64) 45 (23–73) n/a .593
 Race/ethnicity .949
  African American 15 (37.5) 59 (33.9) n/a
  Hispanic 13 (32.5) 63 (36.2) n/a
  White 11 (27.5) 49 (28.2) n/a
  Other 1 (2.5) 3 (1.7) n/a
Underlying medical conditions
 Hepatitis C 3 (7.5) 16 (9.2) 0.72 [0.13, 2.69] .874
 Cardiac disease 1 (2.5) 7 (4.0) 0.51 [0.01, 4.12] .904
 Asthma 3 (7.5) 9 (5.2) 1.42 [0.25, 5.23] .803
 Diabetes 3 (7.5) 11 (6.3) 1.10 [0.19, 4.55] 1.000
 Ever smoked 25 (62.5) 110 (63.2) 0.92 [0.41, 2.10] .979
Time spent outdoors
 Amount of time outdoors has not changed since 2011a 20 (50.0) 92 (52.9) 0.87 [0.42, 1.81] .823
 Hours outdoors per week (median, range)b 19.9 (3.5–45.5) 17.3 (0.0–77.0) n/a .598
Recreational and occupational activitiesc
 Basketball 9 (22.5) 29 (11.5) 2.62 [0.91, 7.31] .077
 Handball 4 (10.0) 19 (10.9) 0.99 [0.22, 3.51] 1.000
 Softball/baseball 5 (12.5) 13 (7.5) 1.90 [0.45, 7.32] .451
 Run/walk 19 (47.5) 104 (59.8) 0.61 [0.28, 1.31] .228
 Work out 20 (50.0) 83 (47.7) 1.11 [0.53, 2.31] .904
 Soccer 3 (7.5) 16 (9.2) 0.84 [0.14, 3.63] 1.000
 Sedentary 7 (17.5) 41 (23.6) 0.66 [0.23, 1.67] .485
Have a job or enrolled in an education program 35 (87.5) 152 (87.4) 0.96 [0.29, 3.72] 1.000
 Administration 3 (8.6) 8 (5.3) 1.79 [0.29, 8.52] .632
 Carpentry/furniture fabrication 1 (2.9) 9 (5.9) 0.48 [0.01, 3.64] .835
 Education program 9 (25.7) 41 (27.0) 0.98 [0.37, 2.47] 1.000
 Food service 5 (14.3) 20 (13.2) 1.08 [0.28, 3.49] 1.000
 Janitorial 8 (22.9) 37 (24.3) 0.96 [0.35, 2.45] 1.000
 Yard crew 4 (11.4) 15 (9.9) 1.27 [0.28, 4.52] .899
 Welding/metalwork 3 (8.6) 5 (3.3) 3.16 [0.33, 41.09] .424
 Other 3 (8.6) 20 (13.2) 0.51 [0.08, 2.12] .513
 Work mainly indoors 28 (87.5) 123 (86.0) 1.23 [0.35, 5.53] .985
  Windows or door usually left open 10 (40.0) 32 (31.7) 3.71 [0.72, 36.78] .149
Breathe in dirt or dust 34 (85.0) 147 (84.5) 1.19 [0.35, 3.52] .917
 Breathe dirt or dust indoors 18 (54.6) 92 (67.2) 0.50 [0.19, 1.28] .164
Residence history
 Highly endemic area 15 (37.5) 58 (33.7) Ref Ref
 Moderately endemic area 22 (55.0) 96 (55.8) 0.88 [0.40, 1.98] .872
 Nonendemic area 3 (7.5) 18 (10.5) 0.69 [0.11, 2.97] .857
Knowledge of coccidioidomycosis
 Correctly described how a person gets coccidioidomycosis 39 (97.5) 156 (89.7) 4.31 [0.64, 186.1] .213
 Heard about coccidioidomycosis prior to current incarceration 10 (25.6) 48 (27.6) 0.91 [0.36, 2.13] .987
Received information about coccidioidomycosis during current incarceration 35 (87.5) 149 (85.6) 1.22 [0.42, 4.39] .930
 From a prison official 7 (17.5) 15 (8.6) 2.26 [0.73, 6.38] .164
 From a health care provider 11 (27.5) 25 (14.4) 2.13 [0.87, 4.97] .102
 From a wall poster 7 (17.5) 53 (30.5) 0.46 [0.15, 1.19] .125
 From a family member 8 (20.0) 6 (3.5) 8.48 [2.22, 39.09] .001
 From TV/media 3 (7.5) 35 (20.1) 0.29 [0.05, 1.10] .076
 From another inmate 15 (37.5) 70 (40.2) 0.89 [0.41, 1.86] .883
a

For case-inmates, before coccidioidomycosis diagnosis; for controls, since January 1, 2011.

b

Among participants whose time spent outdoors had not changed (for case-inmates, before coccidioidomycosis diagnosis; for controls, since January 1, 2011).

c

For case-inmates, before coccidioidomycosis diagnosis; for controls, current activities.

Sixteen of 174 matched controls self-reported that a physician had diagnosed them with coccidioidomycosis (either prior to or during incarceration); however, the results of the case–control study did not change when these persons were excluded from the analysis.

Case-inmates and controls were both knowledgeable about coccidioidomycosis; 195 (91.1%) were able to correctly describe how it is acquired. Only 58 (27.2%) participants had heard of coccidioidomycosis prior to their current incarceration; participants most commonly indicated that they learned about it from other inmates (n = 85, 39.7%) or posters displayed in the prison (n = 60, 28.0%). Case-inmates were more likely than controls to have learned about coccidioidomycosis from their family (20.0% vs. 3.5%, OR = 8.48; CI: [2.22, 39.09], p = .001).

Discussion

We did not find specific outdoor recreational activities, occupations, or time spent outdoors to be associated with coccidioidomycosis in Prison A or B inmates. Therefore, attempting to modify these potential exposures by limiting activity type or duration is probably unlikely to be highly effective in reducing coccidioidomycosis rates.

Although several outbreak investigations have shown associations between dust or dirt exposure and coccidioidomycosis, no data exist that clearly demonstrate risk reduction by limiting outdoor activities (Cummings et al., 2010; Werner, Pappagianis, Heindl, & Mickel, 1972). Similar to our results, one study in a nonprison setting did not find specific recreational activities or time spent outdoors to be associated with illness (Leake et al., 2000). These data suggest that in highly endemic areas where dust exposure is common, limiting outdoor activity alone may not be effective in reducing coccidioidomycosis risk.

It is also unknown if environmental modification can reduce risk. Previous efforts to prevent aerosolization of Coccidioides spores by binding or paving soil have been performed, but the effects on coccidioidomycosis incidence were unclear (California Correctional Health Care, 2012; Smith, Beard, Rosenberger, & Whiting, 1946). Although inmates reported exposures to dirt or dust both outdoors and indoors, our investigation was not designed to evaluate the possible effects of outdoor dust control methods or improved indoor air filtration on risk of disease. It is possible that environmental measures such as these might reduce the risk of Coccidioides spore inhalation, and reducing dust exposure can also result in general respiratory health benefits. Further study in this area is needed.

The primary limitation of our study was that we could not determine whether controls were truly Coccidioides-uninfected since testing was not conducted on controls. Prior Coccidioides infection is believed to confer immunity and is detectable with an antigenic skin test that was unavailable during this investigation (Johnson et al., 2012). Therefore, controls could have been infected either prior to or during incarceration, thus limiting our ability to detect significant differences between case-inmates and controls.

Participants had a good understanding of how coccidioidomycosis is acquired, suggesting the benefit of an active educational campaign. Continuation of ongoing educational efforts may help to alleviate fears and resolve misperceptions about coccidioidomycosis and encourage inmates to promptly seek medical care for relevant symptoms.

Prison officials and public health practitioners face challenges when trying to prevent coccidioidomycosis. Although we did not identify any activities or occupations that could reduce coccidioidomycosis in these prisons, prison officials may consider other strategies: exclusion of persons at high risk, identified by demographic or clinical risk factors or by using an antigenic skin test, is a method to potentially reduce disease and is worthy of future study.

Acknowledgments

We would like to thank Brian Yablon, Meaghan Glowacki, Jasmine Jacobs, Marie A. de Perio, and Gregory A. Burr from the Centers for Disease Control and Prevention. We also thank the staff at Prisons A and B and the study participants for their contributions and cooperation.

Funding

The authors received no financial support for the research, authorship, and/or publication of this article.

Footnotes

The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention

Declaration of Conflicting Interests

The authors disclosed no conflicts of interest with respect to the research, authorship, or publication of this article. For information about JCHC’s disclosure policy, please see the Self-Study Program.

References

  1. Burwell LA, Park BJ, Wannemuehler KA, Kendig N, Pelton J, Chaput E, … Fridkin SK. Outcomes among inmates treated for coccidioidomycosis at a correctional institution during a community outbreak, Kern County, California, 2004. Clinical Infectious Diseases. 2009;49:e113–e119. doi: 10.1086/648119. [DOI] [PubMed] [Google Scholar]
  2. California Correctional Health Care Services Public Health Unit and Quality Management. Coccidioidomycosis in California’s adult prisons 2006–2010. Author; 2012. [Google Scholar]
  3. Cummings KC, McDowell A, Wheeler C, McNary J, Das R, Vugia DJ, Mohle-Boetani JC. Point-source outbreak of coccidioidomycosis in construction workers. Epidemiology and Infection. 2010;138:507–511. doi: 10.1017/S0950268809990999. [DOI] [PubMed] [Google Scholar]
  4. Edwards PQ, Palmer CE. Prevalence of sensitivity to coccidioidin, with special reference to specific and nonspecific reactions to coccidioidin and to histoplasmin. Diseases of the Chest. 1957;31:35–60. doi: 10.1378/chest.31.1.35. [DOI] [PubMed] [Google Scholar]
  5. Galgiani JN, Ampel NM, Blair JE, Catanzaro A, Johnson RH, Stevens DA … Infectious Diseases Society of America. Coccidioidomycosis. Clinical Infectious Diseases. 2005;41:1217–1223. doi: 10.1086/496991. [DOI] [PubMed] [Google Scholar]
  6. Johnson R, Kernerman SM, Sawtelle BG, Rastogi SC, Nielsen HS, Ampel NM. A reformulated spherule-derived coccidioidin (Spherusol) to detect delayed-type hypersensitivity in coccidioidomycosis. Mycopathologia. 2012;174:353–358. doi: 10.1007/s11046-012-9555-6. [DOI] [PubMed] [Google Scholar]
  7. Leake JA, Mosley DG, England B, Graham JV, Plikaytis BD, Ampel NM, … Hajjeh RA. Risk factors for acute symptomatic coccidioidomycosis among elderly persons in Arizona, 1996–1997. Journal of Infectious Diseases. 2000;181:1435–1440. doi: 10.1086/315400. [DOI] [PubMed] [Google Scholar]
  8. Pappagianis D. Coccidioidomycosis in California state correctional institutions. Annals of the New York Academy of Sciences. 2007;1111:103–111. doi: 10.1196/annals.1406.011. annals.1406.011 [pii] [DOI] [PubMed] [Google Scholar]
  9. Smith CE, Beard RR, Rosenberger HG, Whiting EG. Effect of season and dust control on coccidioidomycosis. Journal of the American Medical Association. 1946;132:833–838. doi: 10.1001/jama.1946.02870490011003. [DOI] [PubMed] [Google Scholar]
  10. Werner SB, Pappagianis D, Heindl I, Mickel A. An epidemic of coccidioidomycosis among archeology students in northern California. New England Journal of Medicine. 1972;286:507–512. doi: 10.1056/nejm197203092861003. [DOI] [PubMed] [Google Scholar]
  11. Wheeler C, Lucas KD, Mohle-Boetani JC. Rates and risk factors for coccidioidomycosis among prison inmates, California, USA, 2011. Emerging Infectious Diseases. 2015;21:70–75. doi: 10.3201/eid2101.140836. [DOI] [PMC free article] [PubMed] [Google Scholar]

RESOURCES